FRA:W33 (Switzerland)
Â
Registered Shares
€
28
-0.20 (-0.71%)
Jul 3
Business Description
BioVersys AG
ISIN : CH0210362643
Share Class Description:
FRA:W33: Registered SharesDescription
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.8 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | -1.06 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate Estimate | 503.57 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.52 | |||||
9-Day RSI | 53.5 | |||||
14-Day RSI | 49.58 | |||||
3-1 Month Momentum % | -5.23 | |||||
6-1 Month Momentum % | 16 | |||||
12-1 Month Momentum % | -22.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.1 | |||||
Quick Ratio | 10.1 | |||||
Cash Ratio | 9.27 | |||||
Days Payable | 123.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -386.63 | |||||
Operating Margin % | -2495.38 | |||||
Net Margin % | -2728.75 | |||||
EBITDA Margin % | -2555 | |||||
FCF Margin % | -2764.99 | |||||
OCF Margin % | -2738.04 | |||||
ROE % | -46.66 | |||||
ROA % | -29.73 | |||||
ROIC % | -227.21 | |||||
ROC (Joel Greenblatt) % | -3526.7 | |||||
ROCE % | -32.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 197.08 | |||||
PB Ratio | 2.64 | |||||
Price-to-Tangible-Book | 2.64 | |||||
EV-to-EBIT | -4.68 | |||||
EV-to-EBITDA | -4.75 | |||||
EV-to-Forward-EBITDA | -2.42 | |||||
EV-to-Revenue | 121.4 | |||||
EV-to-Forward-Revenue | 35.13 | |||||
EV-to-FCF | -4.38 | |||||
| Price-to-Net-Current-Asset-Value | 2.67 | |||||
| Price-to-Net-Cash | 3.05 | |||||
Earnings Yield (Greenblatt) % | -21.37 | |||||
FCF Yield % | -14.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioVersys AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.857 | ||
| EPS (TTM) (€) | -4.158 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 35.27 | ||
| 14-Day RSI | 49.58 | ||
| 14-Day ATR (€) | 0.501056 | ||
| 20-Day SMA (€) | 27.83 | ||
| 12-1 Month Momentum % | -22.04 | ||
| 52-Week Range (€) | 22.2 - 43 | ||
| Shares Outstanding (Mil) | 5.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioVersys AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioVersys AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioVersys AG Frequently Asked Questions
What is BioVersys AG(FRA:W33)'s stock price today?
The current price of FRA:W33 is €28.00. The 52 week high of FRA:W33 is €43.00 and 52 week low is €22.20.
When is next earnings date of BioVersys AG(FRA:W33)?
The next earnings date of BioVersys AG(FRA:W33) is .
Does BioVersys AG(FRA:W33) pay dividends? If so, how much?
BioVersys AG(FRA:W33) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BioVersys AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers